This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs). Many of these firms use debt to fund deals, and they complete bolt-on acquisitions for portfolio companies. Developing new products or services.
Firm-Specific and Process Questions – What do you think about our portfolio? So, you could mention a related job, such as strategy, finance, or business development at a portfolio company, and say that you want to return to VC at a higher level eventually. Q: Tell me about the current IPO, M&A, and VC funding markets.
There is some overlap because at the large banks, wealth management clients often get early/privileged access to investment banking products, such as upcoming IPOs, equity/debt offerings, or new investment products. Note that the scope is more limited in “pure” WM roles; you’ll do more non-portfolio work in private banking.)
They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios). Interview Guide : There’s a DCF case study based on Attendo AB, a healthcare facility company in Sweden. What about when the IPO market is shut down and exits look uncertain? in biology.
Growth Equity Interview Questions: Markets & Investments These questions could span a huge range because they could ask you about anything from the current fundraising environment to the IPO and M&A markets to specific markets their portfolio companies operate in. Q: Which portfolio company of ours would you have invested in?
their Enterprise Values are not worth much for a long time): Hedge funds focusing on public biotech companies step into this process after the IPO part, which means they can bet on extreme value inflections based on binary outcomes. There are dozens of other funds in this size range, but this is enough to get you started.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content